A Phase I, Open-label, Randomized, Balanced, Single-dose, Two-Part Study to Assess the Relative Bioavailability of NKTR-118 in Three Formulations Under Fasted (3-Way Crossover) and Fed (2-Way Crossover) Conditions in Male and Non-fertile Female Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 24 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Jun 2011 New trial record